Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats

Brain Research

Volumn 781, Issue 1-2, 1998, Pages 227-235

  Furuya, Yoshiaki ^a   Kagaya, Takaki ^a   Nishizawa, Yukio ^a   Ogura, Hiroo ^a  

^a EISAI CO LTD   (Japan)

Author keywords

(+) HA 966; Apomorphine; Haloperidol; Phencyclidine; Prepulse inhibition; Sp ontaneous locomotor activity

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; DOPAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; PHENCYCLIDINE; STRYCHNINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; HYPERACTIVITY; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STARTLE REFLEX; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032545753     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01245-6     Document Type: Article

References (57)

1. Abduljawad K.A.J., Langley R.W., Bradshaw C.M., Szabadi E. Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by 'prepulses' in man. J. Psychopharmacol. 11:1997;29-34.
2. Allen R.M., Young S.J. Phencyclidine-induced psychosis. Am. J. Psychiatry. 135:1978;1081-1084.
3. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmacol. Exp. Ther. 271:1994;787-794.
4. Bakshi V.P., Geyer M.A. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology. 122:1995;198-201.
5. B.M. Baron, B.L. Harrison, J.H. Kehne, C.J. Schmidt, P.L.M. Van Giersbergen, H.S. White, B.W. Siegel, Y. Senyah, T.C. McCloskey, G.M. Fadayel, V.L. Taylor, M.K. Murawsky, P. Nyce, F.G. Salituro, Pharmacological characterization of MDL 105,519 an NMDA receptor glycine site antagonist, 323 (1997) 181-192.
6. F.E. Bloom, Neurotransmission and the central nervous system, in: J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Gilman (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn., McGraw-Hill, New York, 1996, pp. 267-293.
7. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Arch. Gen. Psychiatry. 47:1990;181-188.
8. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry. 49:1992;206-215.
9. Bristow L.J., Hutson P.H., Thorn L., Tricklebank M.D. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br. J. Pharmacol. 108:1993;1156-1163.
10. Bristow L.J., Landon L., Saywell K.L., Tricklebank M.D. The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat. Psychopharmacology. 118:1995;230-232.
11. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol. Psychiatry. 39:1996;33-41.
12. Danysz W., Essmann U., Bresink I., Wilke R. Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behav. 48:1994;111-118.
13. 1B knockout mice. Psychopharmacology. 132:1997;125-134.
14. Foster A.C., Kemp J.A. HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site. J. Neurosci. 9:1989;2191-2196.
15. French E.D., Vantini G. Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants. Psychopharmacology. 82:1984;83-88.
16. French E.D., Pilapil C., Quirion R. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system. Eur. J. Pharmacol. 116:1985;1-9.
17. Furuya Y., Ogura H. Competitive NMDA and strychnine-insensitive glycine-site antagonists disrupt prepulse inhibition. Pharmacol. Biochem. Behav. 57:1997;909-913.
18. Geyer M.A., Segal D.S., Greenberg B.D. Increased startle responding in rats treated with phencyclidine. Neurobehav. Toxicol. Teratol. 6:1984;161-164.
19. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res. Bull. 25:1990;485-498.
20. Geyer M.A., Wilkinson L.S., Humby T., Robbins T.W. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol. Psychiatry. 34:1993;361-372.
21. Gleason S.D., Shannon H.E. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology. 129:1997;79-84.
22. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D.L. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol. Psychiatry. 32:1992;939-943.
23. Hashimoto A., Nishikawa T., Oka T., Takahashi K. Endogenous D-serine in rats brain: N-methyl-D-aspartate receptor-related distribution and aging. J. Neurochem. 60:1993;783-786.
24. Hutson P.H., Bristow L.J., Thorn L., Tricklebank M.D. R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br. J. Pharmacol. 103:1991;2037-2044.
25. Javitt D.C. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J. Clin. Psychiatry. 9:1980;12-35.
26. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308.
27. Johansson C., Jackson D.M., Svensson L. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat. Psychopharmacology. 116:1994;437-442.
28. Johansson C., Jackson D.M., Zhang J., Svensson L. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Pharmacol. Biochem. Behav. 52:1995;649-654.
29. Johansson C., Jackson D.M., Svensson L. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology. 131:1997;167-173.
30. Johnson K.M. Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine. Fed. Proc. 42:1983;2579-2583.
31. Johnson K., Jones S. Neuropharmacology of phencyclidine: basic mechanism and therapeutic potential. Ann. Rev. Pharmacol. Toxicol. 30:1990;707-750.
32. Jones G.H., Marsden C.A., Robbins T.W. Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: possible disruption of dopamine-dependent mechanisms of the nucleus accumbens. Psychopharmacology. 102:1990;364-372.
33. Jones G.H., Hernandez T.D., Kendall D.A., Marsden C.A., Robbins T.W. Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry. Pharmacol. Biochem. Behav. 43:1992;17-35.
34. Karper L.P., Freeman G.K., Grillon C., Morgan C.A. III, Charney D.S., Krystal J.H. Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis. J. Neuropsychiatry. 8:1996;60-66.
35. Keith V.A., Mansbach R.S., Geyer M.A. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on acoustic startle prepulse inhibition. Biol. Psychiatry. 30:1991;557-566.
36. Kemp J.A., Lessen P.D. The glycine site of the NMDA receptor - five years on. Trends Pharmacol. Sci. 14:1993;20-25.
37. Kretschmer B.D., Kratzer U., Breithecker K., Koch M. ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnesic effects in rats. Eur. J. Pharmacol. 331:1997;109-116.
38. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514.
39. Mansbach R.S., Geyer M.A. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology. 2:1989;299-308.
40. Mansbach R.S. Effect of NMDA receptor ligands on sensorimotor gating in the rat. Eur. J. Pharmacol. 202:1991;61-66.
41. McEntee W.J., Crook T.M. Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology. 111:1993;391-401.
42. Nevins M.E., Nash S.A., Beardsley P.M. Quantative grip strength assessment as a means of evaluating muscle relaxation in mice. Psychopharmacology. 110:1993;92-96.
43. Ornitz E.M., Hanna G.L., de Traversay J. Prestimulation-induced startle modulation in attention-deficit hyperactivity disorder and nocturnal enuresis. Psychophysiology. 29:1992;437-451.
44. 2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats. Psychopharmacology. 124:1996;107-116.
45. 2 dopamine receptor agonist disrupts sensorimotor gating in rats: implication for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology. 3:1990;211-218.
46. Report A.S. The NMDA receptor, NMDA antagonists and epilepsy therapy. Drugs. 44:1992;279-292.
47. 1A receptor agonists block prepulse inhibition of the acoustic startle reflex. J. Pharmacol. Exp. Ther. 263:1992;486-493.
48. Sipes T.A., Geyer M.A. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology. 33:1994;441-448.
49. Sipes T.A., Geyer M.A. 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology. 117:1995;41-48.
50. 1D receptors in the modulation of prepulse inhibition of startle. Psychopharmacology. 125:1996;231-237.
51. Swerdlow N.R., Caine B.C., Braff D.L., Geyer M.A. Neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J. Psychopharmacol. 6:1992;176-190.
52. Swerdlow N.S., Benbow C.H., Zisook S., Geyer M.A., Braff D.L. A preliminary assessment of sensorimotor gating in patients with obsessive-compulsive disorder (OCD). Biol. Psychiatry. 33:1993;298-301.
53. Swerdlow N.R., Paulsen J., Braff D.L., Butters N., Geyer M.A., Swenson M.R. Impaired prepulse inhibition of acoustic and tactile response in patients with Huntington's disease. J. Neurol. Neurosurg. Psychiatry. 58:1995;192-200.
54. Swerdlow N.R., Bakshi V., Geyer M.A. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J. Pharmacol. Exp. Ther. 279:1996;1290-1299.
55. 2 interactions regulate prepulse inhibition in rats? Neuropsychopharmacology. 14:1996;265-274.
56. Willetts J., Balste R., Leander J. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci. 11:1990;423-428.
57. Wood P.L. The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo? Life Sci. 57:1995;301-310.